Max Chat
Share chart Jiangsu Hengrui Medicine Co., Ltd.
Extended chart
Simple chart
About Jiangsu Hengrui Medicine Co., Ltd.
Jiangsu Hengrui Medicine Co., Ltd., фармацевтическая компания, исследует, разрабатывает, производит и продает лекарства по всему миру. Компания разрабатывает Апатиниб, Пиротиниб, Мекапегфилграстим, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Камрелизумаб, Фамитиниб, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR- 1702 и SHR-A1403 для онкологических, метаболических, болевых, аутоиммунных и других показаний. Компания была основана в 1970 году и базируется в Ляньюньгане, Китай.
Main settings
IPO date
2000-09-07
ISIN
CNE0000014W7
Industry
Pharmaceuticals
Sector
Health Care
Валюта
cny
Валюта отчета
cny
Див.доход ао
0.3484
Дивиденд ао
0.16
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 10.52 | 1 |
| P/BV | 6.39 | 1 |
| P/E | 46.45 | 3 |
Efficiency
| Title | Value | Grade |
| ROA | 13.49 | 4 |
| ROE | 14.74 | 4 |
| ROIC | 0 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0.7857 | 7.86 |
| Average dividend growth | 13.8 | 10 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 0.0206 | 10 |
| Debt/Ratio | 0.0019 | 10 |
| Debt/Equity | 0.0878 | 10 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 0.9014 | 1 |
| Yield Ebitda, % | -41.18 | 0 |
| Yield EPS, % | 0.4288 | 1 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 53.26 ¥ | 0 ¥ | 0 ¥ | 0 % | 0 % | 0 % |
| Week | 51.9 ¥ | 0 ¥ | 0 ¥ | +2.62 % | 0 % | 0 % |
| Month | 53.89 ¥ | 51.58 ¥ | 53.76 ¥ | -1.17 % | 0 % | 0 % |
| Three month | 51.1 ¥ | 48 ¥ | 55.94 ¥ | +4.23 % | 0 % | 0 % |
| Half a year | 47.55 ¥ | 42.84 ¥ | 55.94 ¥ | +12.01 % | 0 % | 0 % |
| Year | 48.68 ¥ | 40 ¥ | 56.01 ¥ | +9.41 % | 0 % | 0 % |
| 3 years | 35.1 ¥ | 31.9 ¥ | 56.01 ¥ | +51.74 % | 0 % | 0 % |
| 5 years | 92.73 ¥ | 27.74 ¥ | 115.01 ¥ | -42.56 % | 0 % | 0 % |
| 10 years | 27.74 ¥ | 27.74 ¥ | 282.71 ¥ | +192 % | 0 % | 0 % |
| Year to date | 45.5 ¥ | 42.67 ¥ | 55.94 ¥ | +17.05 % | 0 % | 0 % |
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
| Pacer CSOP FTSE China A50 ETF | 1.99833 | 14.34 | 0.7 |
| Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF | 0.05659 | 4.26 | 0.20 |
| 1.03 | 9.3 | 0.45 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Jianjun Liu | Financial Director | N/A | 1978 (47 years) |
| Ms. Su Mei Jiang | Deputy General Manager | N/A | 1965 (60 years) |
| Mr. Jie Ping Sun | Deputy GM & Director | N/A | 1970 (55 years) |
| Mr. Hong Bin Dai | GM & Director | N/A | 1976 (49 years) |
| Dr. Lian Shan Zhang Ph.D. | Deputy GM & Director | N/A | 1962 (63 years) |
| Ms. Xiao Han Liu | Secretary of the Board of Directors | N/A | 1985 (40 years) |
| Mr. Ya Ping Shen | Deputy General Manager | N/A | 1964 (61 year) |
| Mr. Cheng Liao | Deputy General Manager | N/A | 1975 (50 years) |
| Mr. Hongsen Wang | Deputy General Manager | N/A | 1970 (55 years) |
| Dr. Ningjun Jiang M.D., Ph.D. | Deputy GM & Director | 1961 (64 years) |
About company
Address: China, Lianyungang, No. 38 Huanghe Road - Open in google maps, Open in yandex maps
Website: https://www.hrs.com.cn
Website: https://www.hrs.com.cn
